We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

CDK3/CyclinE1 Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant full-length human CDK3 and Cyclin E1 were co-expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag on both proteins. CDK3/CyclinE1is a member of the cyclin-dependent protein kinase family and promotes entry into S phase, in part by activating members of the E2F family of transcription factors. CDK3 can also associate with cyclin C and phosphorylates the retinoblastoma 1 protein to promote exit from G0. The CDK3 gene has been mapped to chromosomal location of 17q22-qter, telomeric to the BRCA1 gene by somatic cell hybrids analysis (1). The presence of a sin...

Expand to Read More »

  • Print
  • Email
  • Prices valid for US customers only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart
CDK3/CyclinE1 Kinase Enzyme System
Close Window

CDK3/CyclinE1 Kinase Enzyme System  Components

10μg
- V4490 $ 406.00 Add to cart

CDK3/CyclinE1 Kinase Enzyme System

Close Window

CDK3/CyclinE1 Kinase Enzyme System

 Components

1mg
- V6281 $ 5,990.00 Add to cart
ADP-Glo™ Kinase Assay + CDK3/CyclinE1 Kinase Enzyme System
Close Window

ADP-Glo™ Kinase Assay + CDK3/CyclinE1 Kinase Enzyme System  Components

  • CDK3/CyclinE1 Kinase Enzyme System

    V44901 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V4491 $ 808.00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V4490, V6281, V4491 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V4491 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V4491 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V4491 U.S. Pat. Nos. 7,741,067, 8,361,739, 8,603,767 and other patents and patents pending.

V4491 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V4491 U.S. Pat. No. 8,183,007 and other patents and patents pending.

V4491 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V4491 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.